Photo of Amar Gajjar and Giles Robinson from their Twitter
Sep 8, 2023, 12:49
Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas.
Quoting Amar Gajjar on Twitter:
”SJ901, named after the last 3 digits of the experimental SpringWorks drug, offers a new targeted therapeutic approach against pediatric low-grade gliomas. Giles Robinson.”
For the article click here.
Source: Amar Gajjar/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19